The CDC has posted a preliminary list of ICD-10-CM changes for October 1 (aka ICD-10-CM 2017), and just in case you don’t have time right now to sort through about 2,000 new codes, here are some relevant to interventional oncology practices.
The five-year freeze coders and providers have enjoyed with the ICD-10-CM system is about to end on October 1, 2016. You can anticipate significant changes going by the information CMS released for public review. If accepted, alterations will include the following:
Plus: The ICD-10 Coordination and Maintenance Committee reviewed proposals for updating ICD-10-CM and PCS. If approved, these would be included in the October 1, 2017, classification system addenda for FY 2018.
Updates allow new or revised codes to encompass recent advances and trends in healthcare. The new codes have arrived sooner than many experts expected.
The committee reviewed 24 diagnosis proposals, such as:
Expect to Go Beyond Classical in Hodgkin Lymphoma
An important change you can anticipate later this year is for the diagnosis codes for Hodgkin lymphoma. Later this year, the diagnosis codes C81.10 (Nodular sclerosis classical Hodgkin lymphoma, unspecified site) to C81.79 (Other classical Hodgkin lymphoma, extranodal and solid organ sites) will undergo a uniform elimination of the term ‘classical’ in the code descriptors.
What this means? This means codes C81.10 to C81.79 will have revised descriptors. Check these changes in the examples below.
How does this change impact your choice of codes? These revisions for the ICD-10-CM codes for Hodgkin lymphoma do not impact the available choices you have to report this condition. The choice of codes will continue to be governed by the histological subtype of Hodgkin lymphoma.
Why the revisions? These revisions will align the codes to the accepted classification of Hodgkin lymphoma. This revision in codes C81.10 to C81.49 aligns the codes to the widely accepted classification of Hodgkin lymphoma by the World Health Organization (WHO) (Refer to the box). The revised descriptors retain the specificity for each histological type of classical Hodgkin lymphoma.
Make Room for All Subtypes in Hodgkin Lymphoma
The proposed revisions to the ICD-10-CM codes will encompass all groups in the histological classification.
Does this add specificity? These revisions will introduce more specificity to the following codes:
The elimination of the term ‘classical’ in the codes C81.70 to C81.79 makes room for the nodular lymphocyte predominant type of Hodgkin lymphoma, which is the second group of Hodgkin lymphoma in the WHO classification.
Start preparing: In the next few months, make sustained efforts to refine ICD-10-CM coding practices. Enlist the revisions relevant to your practice and train your staff.
Be warned: The list is not yet final. The CDC will post the final addendum in June.
Resource: To review the complete list, head to ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD10CM/2017/NewICD10CMCodes_FY2017.txt.
classical Hodgkin lymphoma, unspecified siteclassical Hodgkin lymphoma, lymph nodes of head, face, and neckclassical Hodgkin lymphoma, intrathoracic lymph nodesclassical Hodgkin lymphoma, intra-abdominal lymph nodesclassical Hodgkin lymphoma, lymph nodes of axilla and upper limbclassical Hodgkin lymphoma, lymph nodes of inguinal region and lower limbclassical Hodgkin lymphoma, intrapelvic lymph nodesclassical Hodgkin lymphoma, spleenclassical Hodgkin lymphoma, lymph nodes of multiple sitesclassical Hodgkin lymphoma, extranodal and solid organ sites.